spacer
spacer

PDBsum entry 3f7b

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Lyase PDB id
3f7b

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
257 a.a. *
Ligands
AG5 ×2
Metals
_ZN ×2
Waters ×263
* Residue conservation analysis
PDB id:
3f7b
Name: Lyase
Title: Crystal structure of soluble domain of ca4 in complex with small molecule.
Structure: Carbonic anhydrase 4. Chain: a, b. Fragment: soluble domain. Synonym: carbonic anhydrase iv, ca-iv, carbonate dehydratase iv. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: ca4. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
2.05Å     R-factor:   0.194     R-free:   0.252
Authors: S.E.Greasley,R.A.A.Ferre,T.A.Pauly,R.Paz
Key ref: W.Vernier et al. (2010). Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: structure-based drug design, synthesis, and biological evaluation. Bioorg Med Chem Lett, 18, 3307-3319. PubMed id: 20363633
Date:
07-Nov-08     Release date:   22-Sep-09    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P22748  (CAH4_HUMAN) -  Carbonic anhydrase 4 from Homo sapiens
Seq:
Struc:
312 a.a.
257 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.4.2.1.1  - carbonic anhydrase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: hydrogencarbonate + H+ = CO2 + H2O
hydrogencarbonate
+ H(+)
= CO2
+ H2O
      Cofactor: Zn(2+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
Bioorg Med Chem Lett 18:3307-3319 (2010)
PubMed id: 20363633  
 
 
Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: structure-based drug design, synthesis, and biological evaluation.
W.Vernier, W.Chong, D.Rewolinski, S.Greasley, T.Pauly, M.Shaw, D.Dinh, R.A.Ferre, J.W.Meador, S.Nukui, M.Ornelas, R.L.Paz, E.Reyner.
 
  ABSTRACT  
 
A novel series of potent thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV was discovered using structure-based drug design. Synthesis, structure-activity relationship, and optimization of physicochemical properties are described. Low nanomolar potency was achieved, and selected compounds with improved thermodynamic solubility showed promising in vitro inhibition of carbonic anhydrase activity in rabbit iris ciliary body homogenate.
 

 

spacer

spacer